In a move that could as well come as a surprise to many, for the very first time in India, couples who are looking to avail In Vitro Fertilisation – IVF treatment for conception can depend upon a globally preferred, automated egg-freezing technology so as to enable a successful pregnancy along with the healthy birth of their child. 

DSS Imagetech’s, Hana Health which is a market leader when it comes to Molecular Diagnostics, Life Sciences, and Biotechnology, has gone ahead and exclusively partnered with Overture Life, which is a leading developer of automated IVF technologies and also the first company to attain live births from both robotic fertilization as well as robotic egg freezing, to bring their landmark automated egg-freezing technology in India — DaVitri.

Apparently, Overture Life is the first company to celebrate the feat of live births from both robotic fertilization as well as robotic egg freezing. The DaVitri platform has become the very first to receive regulatory clearance from certain major authorities in the US, UK as well as Europe which helps the fertility clinics to get egg-freezing standardized, which, by the way, is one of the most technically demanding steps when it comes to the process of IVF. This partnership brings to the fore the automated vitrification platform, DaVitri, into regular clinical use in India, hence helping the clinics to standardize one of the most technically demanding steps of IVF, expand the procedural capacity, and simultaneously support embryologists at a time when the fertility demand across the country is witnessing an unmatched surge.

According to Sr. Vice President, IVF Division, Hana Health by DSS, Ashim Ghatak, “DaVitri addresses a core bottleneck in embryology that has historically limited both scale and reproducibility. For patients, every IVF cycle represents hope, time, and an enormous emotional and financial investment. The tiniest variations during egg freezing can affect everything that follows. By standardising vitrification under controlled, data-driven protocols, automation improves predictability at the earliest stages of treatment, supporting higher overall embryo yield and reducing the likelihood of repeated cycles.”

It is worth noting that variability in egg freezing as well as warming still remains a major contributor when it comes to inconsistent outcomes along with repeated treatment cycles, therefore resulting in both emotional as well as financial drain for couples who are undergoing the treatment. What DaVitri does is that it empowers clinics to widen their capacity by way of automating vitrification through a regulated, microfluidic system, hence decreasing variability at the stage of critical egg-freezing. This supports a hope of the couple for a child with the most consistent technology that is available.

Says the Chief Executive Officer of Overture Life. Hans Gangeskar, “India’s fertility clinics are serving a growing and diverse patient population under intense capacity pressure. DaVitri enables clinics to expand access and scale up while protecting consistency and clinical rigour, without sacrificing the highest standards that families deserve. The collaboration positions DaVitri as a forthcoming, service-supported system for Indian clinics that are seeking to modernize IVF workflow.”

Notably, when it comes to clinical evaluations, DaVitri has gone on to showcase measurable enhancements in post-thaw embryo development vis-à-vis manual methods, reinforcing the growing relevance of Automated Egg-Freezing Technology in India. At the same time, it enables small and large centralised laboratories to process significantly more procedures without any increase in staffing. By reducing infrastructure requirements from millions of dollars to just a fraction of that cost, Automated Egg-Freezing Technology in India is helping smaller clinics and satellite locations deliver advanced fertility services that were previously out of reach.

Medical Director at Bloom IVF, CEO at WAGO, Dr. Hrishikesh Pai, says that “Automation in general is the future of IVF procedures, and the microfluidics technology from Overture represents a decisive next step in advancing precision and efficiency in cryopreservation.”